Private medical services provider MedLife has announced the acquisition of the majority stake (65 percent) of the Badea Medica excellence centre in Cluj-Napoca, which provides a wide range of medical services, with a special focus on the abdominal pathology segment: gastroenterology, internal medicine, dermatology, and pain therapy.
“Cluj represents one of the most important interest points in our development plan. We first opened a medical test lab and a labour medicine centre in this city, then we expanded with a large clinic – the MedLife Hyperclinic. Two years ago we also added the hospital services part as we became a shareholder in the Humanitas hospital. As we want to provide patients with an even wider range of services as well as customized subscriptions to the tens of thousands of clients in companies, we have decided to team up with the specialists at the Badea Medica excellence centre, who can offer integrated services at the highest standards. We will continue our acquisition programme both in Romania as well as in the neighbouring countries we are prospecting, following the plan we’ve presented to investors and shareholders,” said Mihai Marcu, the President and CEO of MedLife Group.
Badea Medica is MedLife’s 23rd acquisition to date, following its takeover of Hungarian Rozsakert Medical Center, announced in January 2019.
“We’ve always been focused on services of the highest quality and we’ve been honoured by our patients’ trust in our services and exceptional team of specialists. The fact that we’re becoming a part of the largest private medical services group in Romania and that we share the same values is an honour for us and encourages to be even better. We’ll have the opportunity to develop the business and make an important step in the company’s evolution. This way we will increase the complexity of the medical service and offer patients the best conditions and solutions,” said Prof Dr Radu Ion Badea, the founder of the Badea Medica centre.
MedLife ended Q1 2019 with a consolidated turnover of RON 224.9 million, a 27.6 percent growth compared to the same period of last year. If the company’s acquisition and development plans are successful, it may exceed EUR 200 million in turnover in 2019.